Pharmaceutical News

RSS

Cancer drug Taxotere given the green light to treat head and neck cancer

Following promising results in a phase III trial, the drug Taxotere has been given the green light for use in people with head and neck cancer.

2 Oct 2007

FDA warns against cold and cough remedies made for children

Safety experts in the United States are warning parents about buying over-the-counter cold and cough remedies, specifically marketed for children.

2 Oct 2007

Taxotere (docetaxel) granted FDA approval to treat locally advanced head and neck cancer prior to chemo and surgery

Sanofi-aventis announced that the U.S. Food and Drug Administration (FDA) has approved Taxotere (docetaxel) Injection Concentrate in combination with cisplatin and 5-fluorouracil for induction therapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN) before patients undergo chemoradiotherapy and surgery.

2 Oct 2007

FDA tackles illegal hydrocodone products

The U.S. Food and Drug Administration has announced its intention to take enforcement action against companies marketing unapproved prescription drug products containing hydrocodone, a narcotic widely used to treat pain and suppress coughs.

29 Sep 2007

FDA approves Lamisil for child treatment of scalp ringworm

The U.S. Food and Drug Administration announced the approval of Lamisil Oral Granules for the treatment of tinea capitis, a fungal infection of the scalp, in children ages 4 years and older.

29 Sep 2007

FDA approves Afluria in time for flu season

The U.S. Food and Drug Administration today approved Afluria, an additional seasonal influenza vaccine for the immunization of people ages 18 and older.

29 Sep 2007

Vanda Pharmaceuticals submits iloperidone NDA

Vanda Pharmaceuticals has announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for iloperidone, an investigational atypical antipsychotic for the treatment of schizophrenia.

27 Sep 2007

London School of Hygiene to play key role in global collaboration on adverse drug reactions

The London School of Hygiene & Tropical Medicine is to be a key player in the first global research collaboration aimed at identifying the genetic markers related to Adverse Drug Reactions (ADRs).

27 Sep 2007

Watson Pharmaceuticals receives FDA approval for generic Accuneb

Watson Pharmaceuticals, Inc. has announced that it has received final approval from the United States (U.S.) Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for albuterol sulfate inhalation solution in the 0.021% (base) and 0.042% (base) strengths.

27 Sep 2007

Potential new weight-loss wonder drug

More than 60 percent of American women are overweight, with nearly a third falling into the category of obese and at greater risk of cancer, heart disease and diabetes.

27 Sep 2007

FDA warning on use of Fentora (fentanyl buccal)

The Food and Drug Administration is alerting health care professionals and consumers to concerns over the use of Fentora (fentanyl buccal) tablets after recent reports of deaths and other adverse events.

27 Sep 2007

Axitinib shows promise for patients with advanced kidney cancer

Barcelona, Spain: A new drug has shown promise in patients with advanced kidney cancer whose options run out after their tumour fails to respond to the cutting edge therapy.

27 Sep 2007

Ten years of pharmaceutical television advertisements have Pennsylvanians asking their docs about medications

poll of Pennsylvania adults 10 years after the first direct-to-consumer pharmaceutical television advertisement ran suggests that nearly half of the participants have asked their doctor about a specific prescription drug or medical procedure they saw advertised.

27 Sep 2007

Warning about dangerous potential of pain drug Fentora

The Food and Drug Administration (FDA) in the United States has warned doctors about the dangers of a drug used to treat pain in cancer sufferers.

26 Sep 2007

NanoBio expands drug development team

NanoBio Corporation has announced the addition of four new scientists to its drug development team.

26 Sep 2007

New skin patch treatment for Alzheimer's approved by the European Commission

A skin patch to treat Alzheimer's disease has been approved by the European Commission.

25 Sep 2007

FDA fast tracks PI-88 for the treatment of post resection liver cancer

Progen Pharmaceuticals Limited has announced that its investigational anti-cancer drug PI-88 has been awarded Fast Track status by the U.S. Food and Drug Administration (FDA).

25 Sep 2007

Adnexus Therapeutics to become a subsidiary of Bristol-Myers Squibb

Bristol-Myers Squibb and Adnexus Therapeutics have announced the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire privately held Adnexus Therapeutics, developer of a new therapeutic class of biologics called Adnectins.

25 Sep 2007

New Pfizer HIV drug approved for sale in Europe

Drug giant Pfizer has been given approval for it's new HIV drug Celsentri to go on sale in Europe.

24 Sep 2007

New synthetic version of the drug heparin

Researchers at the University of North Carolina at Chapel Hill have patented a synthetic version of the drug heparin, called Recomparin, that is less complex chemically and should be easier to produce than previous forms.

24 Sep 2007